GRAIL, LLC Financials
| GRAL Stock | 28.18 0.95 3.26% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 10.6579 |
|
|
The financial analysis of GRAIL, LLC is a critical element in measuring its lifeblood. Investors should not minimize GRAIL, LLC's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
GRAIL, | Select Account or Indicator |
Understanding current and past GRAIL, LLC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GRAIL, LLC's financial statements are interrelated, with each one affecting the others. For example, an increase in GRAIL, LLC's assets may result in an increase in income on the income statement.
GRAIL, LLC Stock Summary
GRAIL, LLC competes with Universal Insurance, FactSet Research, ServiceNow, Fidelity National, and Cadence Design. GRAIL, LLC is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 384747101 |
| Older Symbol | GRALV |
| Location | California; U.S.A |
| Business Address | 1525 OBrien Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | grail.com |
| Phone | 833 694 2553 |
GRAIL, LLC Key Financial Ratios
| Return On Equity | -0.66 | ||||
| Operating Margin | (3.02) % | ||||
| Price To Sales | 7.86 X | ||||
| Revenue | 125.59 M | ||||
| Gross Profit | (78.02 M) |
GRAIL, LLC Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 706.3M | 9.7B | 5.6B | 3.9B | 3.0B | 3.8B | |
| Other Current Liab | 54.0M | 66.4M | 104.1M | 129.1M | 58.8M | 79.9M | |
| Net Debt | (112.7M) | (124.4M) | (145.6M) | (12.9M) | (146.1M) | (138.8M) | |
| Retained Earnings | (1.6B) | (911.5M) | (6.3B) | (7.8B) | (9.8B) | (9.3B) | |
| Accounts Payable | 24.5M | 17.6M | 17.5M | 19.7M | 4.8M | 4.6M | |
| Cash | 170.2M | 221.2M | 241.6M | 97.3M | 214.2M | 185.9M | |
| Other Current Assets | 12.4M | 14.7M | 15.7M | 14.7M | 13.0M | 14.4M | |
| Total Liab | 144.5M | 307.4M | 955.9M | 267.6M | 479.9M | 449.1M | |
| Total Current Assets | 595.9M | 242.7M | 295.6M | 156.1M | 819.9M | 860.9M | |
| Common Stock | 151K | 10.3B | 11.0B | 11.4B | 34K | 32.3K | |
| Short Term Debt | 5.4M | 13.8M | 13.3M | 14.8M | 13.3M | 12.0M |
GRAIL, LLC Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 30.4M | 658.8M | 15.6M | (144.6M) | 116.1M | 82.6M | |
| Free Cash Flow | (243.9M) | (758.1M) | (584.2M) | (608.7M) | (582.4M) | (611.5M) | |
| Depreciation | 7.6M | 58.4M | 154.8M | 158.7M | 158.1M | 88.3M | |
| Other Non Cash Items | 9.4M | 625.2M | 5.1B | 644.4M | 1.4B | 1.2B | |
| Capital Expenditures | 11.9M | 69.9M | 22.9M | 12.9M | 5.2M | 4.9M | |
| Net Income | (312.2M) | (1.2B) | (5.4B) | (1.5B) | (2.0B) | (2.1B) | |
| End Period Cash Flow | 174.8M | 802.0M | 241.6M | 101.5M | 217.6M | 279.1M |
GRAIL, Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GRAIL, LLC's current stock value. Our valuation model uses many indicators to compare GRAIL, LLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GRAIL, LLC competition to find correlations between indicators driving GRAIL, LLC's intrinsic value. More Info.GRAIL, LLC is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, GRAIL, LLC's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value GRAIL, LLC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.GRAIL, LLC Systematic Risk
GRAIL, LLC's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GRAIL, LLC volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on GRAIL, LLC correlated with the market. If Beta is less than 0 GRAIL, LLC generally moves in the opposite direction as compared to the market. If GRAIL, LLC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GRAIL, LLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GRAIL, LLC is generally in the same direction as the market. If Beta > 1 GRAIL, LLC moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in GRAIL, LLC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GRAIL, LLC's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of GRAIL, LLC growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
GRAIL, LLC March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GRAIL, LLC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GRAIL, LLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of GRAIL, LLC based on widely used predictive technical indicators. In general, we focus on analyzing GRAIL, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GRAIL, LLC's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.91 | |||
| Information Ratio | 0.0996 | |||
| Maximum Drawdown | 48.65 | |||
| Value At Risk | (12.74) | |||
| Potential Upside | 18.43 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GRAIL, LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy GRAIL, Stock please use our How to buy in GRAIL, Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GRAIL, LLC. If investors know GRAIL, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GRAIL, LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (63.54) | Revenue Per Share | Quarterly Revenue Growth 0.261 | Return On Assets | Return On Equity |
The market value of GRAIL, LLC is measured differently than its book value, which is the value of GRAIL, that is recorded on the company's balance sheet. Investors also form their own opinion of GRAIL, LLC's value that differs from its market value or its book value, called intrinsic value, which is GRAIL, LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GRAIL, LLC's market value can be influenced by many factors that don't directly affect GRAIL, LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GRAIL, LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GRAIL, LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GRAIL, LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.